Beyond GI effects, patients should watch for: Headaches , particularly during the first two weeks and after dose escalations Insomnia or sleep disruption, which affects some patients more than others Muscle pain and body aches , often reported in the first week of a new dose Anxiety , which some patients experience as appetite suppression creates unfamiliar hunger signals Joint pain , reported less frequently but worth monitoring Injection site reactions , including redness, itching, and localized swelling Menstrual changes , as rapid weight loss and hormonal shifts can affect cycle regularity Fatigue , especially during the caloric restriction phase Hair loss , a known but usually temporary effect of significant weight loss If side effects become unmanageable at any dose, the microdose tirzepatide schedule offers an alternative approach
The higher bioavailability translates to more predictable therapeutic exposure
Does not contain: Wheat, soy, dairy, eggs, gluten, tree nuts, peanuts, sesame, artificial colors, artificial sweeteners, coatings, shellacs, GMOs, unnecessary binders, fillers, preservatives, trans fat, or hydrogenated oils
OVERDOSAGE Overdoses have been reported with other GLP-1 receptor agonists
Build this timing into your patient protocols up front